Skip to main content
. 2017 Sep 14;129(23):879–892. doi: 10.1007/s00508-017-1248-1

Table 5.

Clinical events in Austrian patients and all CLARIFY patientsa with stable CAD (N, [%])c

Event Austrian patients with stable CAD (N = 424) CLARIFY patients with stable CAD (N = 31954)
All cause death 25 (5.9) 2519 (7.9)
Cardiovascular death 15 (3.5) 1604 (5.0)
Non-cardiovascular death 10 (2.4) 915 (2.9)
MI (fatal or non-fatal) 14 (3.3) 1092 (3.4)
Stroke (fatal or non-fatal) 8 (1.9) 678 (2.1)
Cardiovascular death or non-fatal MI 24 (5.7) 2329 (7.3)
Cardiovascular death, non-fatal MI or non-fatal stroke 30 (7.1) 2777 (8.7)
Non-fatal MI 9 (2.1) 786 (2.5)
Non-fatal stroke 6 (1.4) 525 (1.6)
Unstable angina 34 (8.0) 3405 (10.7)
Major bleeding 9 (2.1) 437 (1.4)
Coronary angiography 67 (15.8) 4562 (14.3)
PCI 34 (8.0) 2106 (6.6)
CABG 6 (1.4) 429 (1.3)
Revascularization (PCI or CABG) 39 (9.2) 2487 (7.8)
TIA 5 (1.2) 823 (2.6)
Hospitalization for CHF 15 (3.5) 1632 (5.1)
Cardiovascular death, non-fatal MI, non-fatal stroke or revascularization 30 (7.1) 2777 (8.7)
MI (fatal or non-fatal) or revascularization 42 (9.9) 3068 (9.6)
MI (fatal or non-fatal) or revascularization or unstable angina 56 (13.2) 5097 (16.0)
Cardiovascular hospitalization 124 (29.2) 9713 (30.4)

CABG coronary artery bypass graft, CHF congestive heart failure, MI myocardial infarction, N number of patients, PCI percutaneous coronary intervention, TIA transient ischemic attack

acomplete CLARIFY population excluding Austria

bpercentages are of the data available